Recordati SpA (LTS:0KBS) Research & Development : €278 Mil (TTM As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Recordati SpA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Recordati SpA's Research & Development for the three months ended in Sep. 2024 was €66 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was €278 Mil.

Recordati SpA Research & Development Historical Data

The historical data trend for Recordati SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Research & Development Chart

Recordati SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

129.68

146.24

166.14

220.10

255.75

Recordati SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Research & Development	Get a 7-Day Free Trial															63.20	73.51	67.32	71.82	65.71

Recordati SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €278 Mil.

Recordati SpA (LTS:0KBS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Recordati SpA Research & Development Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Recordati SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (LTS:0KBS) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

RICFY:USA REC:Italy RECm:UK RER1:Germany RER1:Germany REC:Austria

Address

Via Matteo Civitali 1, MIlan, ITA, 20148

Website

https://www.recordati.com

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines